Erzofri extended-release

Shandong Luye Pharmaceutical Co., Ltd.🇺🇸 United States

FDA Page

Effective Date: Mar 9, 2026
Approval ID: 492bf9dd-868e-421a-92db-8cca8973aac1
Products: 6 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ERZOFRI safely and effectively. See full prescribing information for ERZOFRI . ERZOFRI (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006

Quick Stats

Total Products6

Labelers1

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.